Release Date: 28/10/20 12:57 Summary: Updated Chairman's Address to Shareholders Price Sensitive: No Download Document 271.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%